Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.

Literature DB >> 18426899

Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.

Andrea Endimiani¹, Lenore L Carias, Andrea M Hujer, Christopher R Bethel, Kristine M Hujer, Federico Perez, Rebecca A Hutton, William R Fox, Geraldine S Hall, Michael R Jacobs, David L Paterson, Louis B Rice, Stephen G Jenkins, Fred C Tenover, Robert A Bonomo.

Abstract

The presence of plasmid-mediated quinolone resistance genes [i.e., qnrA, qnrB, qnrS, aac(6')-Ib-cr, and qepA] was evaluated among 42 bla(KPC)-containing Klebsiella pneumoniae isolates collected in the eastern United States. One isolate carried the bla(KPC-3) and qnrB19 genes on the same conjugative plasmid, whereas another carried the bla(KPC-3) and qnrA1 genes on separate plasmids.

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 2008 PMID： 18426899 PMCID： PMC2443894 DOI： 10.1128/AAC.00158-08

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

15 in total

1. Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniae.

Authors: D L Paterson; L B Rice; R A Bonomo
Journal: Clin Microbiol Infect Date: 2001-12 Impact factor: 8.067

2. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States.

Authors: A Robicsek; J Strahilevitz; D F Sahm; G A Jacoby; D C Hooper
Journal: Antimicrob Agents Chemother Date: 2006-08 Impact factor: 5.191

3. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.

Authors: Chi Hye Park; Ari Robicsek; George A Jacoby; Daniel Sahm; David C Hooper
Journal: Antimicrob Agents Chemother Date: 2006-09-05 Impact factor: 5.191

4. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene.

Authors: Rodrigo E Mendes; Jan M Bell; John D Turnidge; Qiwen Yang; Yunsong Yu; Ziyong Sun; Ronald N Jones
Journal: Antimicrob Agents Chemother Date: 2007-12-17 Impact factor: 5.191

5. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.

Authors: Dóra Szabó; Robert A Bonomo; Fernanda Silveira; A William Pasculle; Carla Baxter; Peter K Linden; Andrea M Hujer; Kristine M Hujer; Kathleen Deeley; David L Paterson
Journal: J Clin Microbiol Date: 2005-10 Impact factor: 5.948

Review 6. The worldwide emergence of plasmid-mediated quinolone resistance.

Authors: Ari Robicsek; George A Jacoby; David C Hooper
Journal: Lancet Infect Dis Date: 2006-10 Impact factor: 25.071

7. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Authors: Simona Bratu; David Landman; Robin Haag; Rose Recco; Antonella Eramo; Maqsood Alam; John Quale
Journal: Arch Intern Med Date: 2005-06-27

Review 8. Class A carbapenemases.

Authors: Jan Walther-Rasmussen; Niels Høiby
Journal: J Antimicrob Chemother Date: 2007-06-26 Impact factor: 5.790

9. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals.

Authors: M Edelstein; M Pimkin; I Palagin; I Edelstein; L Stratchounski
Journal: Antimicrob Agents Chemother Date: 2003-12 Impact factor: 5.191

10. Is plasmid-mediated quinolone resistance a clinically significant problem?

Authors: L Poirel; V Cattoir; P Nordmann
Journal: Clin Microbiol Infect Date: 2008-01-07 Impact factor: 8.067

44 in total

1. CMY-2-producing Escherichia coli in the nose of pigs.

Authors: Andrea Endimiani; Markus Hilty; Vincent Perreten
Journal: Antimicrob Agents Chemother Date: 2012-06-05 Impact factor: 5.191

2. Changes in aac(6')-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of Escherichia coli collected from 1991 through 2005.

Authors: Gabriela Warburg; Maya Korem; Ari Robicsek; Dalia Engelstein; Allon E Moses; Colin Block; Jacob Strahilevitz
Journal: Antimicrob Agents Chemother Date: 2008-12-22 Impact factor: 5.191

3. Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae.

Authors: Henrietta Abodakpi; Kai-Tai Chang; Song Gao; Ana María Sánchez-Díaz; Rafael Cantón; Vincent H Tam
Journal: Antimicrob Agents Chemother Date: 2019-01-29 Impact factor: 5.191

4. In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases.

Authors: Andrea Endimiani; Yuvraj Choudhary; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2009-06-15 Impact factor: 5.191

5. Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.

Authors: Anna Maria Dionisi; Claudia Lucarelli; Slawomir Owczarek; Ida Luzzi; Laura Villa
Journal: Antimicrob Agents Chemother Date: 2009-06-15 Impact factor: 5.191

6. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.

Authors: Andrea Endimiani; Gopi Patel; Kristine M Hujer; Mahesh Swaminathan; Federico Perez; Louis B Rice; Michael R Jacobs; Robert A Bonomo
Journal: Antimicrob Agents Chemother Date: 2009-11-09 Impact factor: 5.191